Fat Metabolizing Hormone Studied In Humans
The endogenous substance FGF21 has beneficial effects on blood lipids and glucose levels in rodents and monkeys, and is an interesting candidate for treatment of type 2 diabetes. Scientists at Karolinska Institutet have now examined if FGF21 has a similar function in humans. The results are presented in the journal Cell Metabolism.
More: continued here
Filed under: Diabetes on August 11th, 2008